Malata African & Caribbean Market MARCS-CMS 485911 —
- Food & Beverages
Recipient NameEdward Siaw, Dilys Wireko
- Malata African & Caribbean Market
185 McClellan Street
Bronx, NY 10456
- Issuing Office:
- Division of Northeast Imports-Compliance Branch
Dear Mr. Siaw and Ms. Wireko,
The Food & Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter NYK-2016-17, dated December 30, 2015. Based on our evaluation it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Division of Northeast Imports-Compliance Branch
U.S. Food and Drug Administration